Jane Street reports 4.3% stake in GeoVax Labs
GeoVax Labs, Inc. is the subject of an amended Schedule 13G filing by Jane Street Group, LLC and its subsidiaries Jane Street Capital, LLC and Jane Street Global Trading, LLC.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
GeoVax Labs, Inc. is the subject of an amended Schedule 13G filing by Jane Street Group, LLC and its subsidiaries Jane Street Capital, LLC and Jane Street Global Trading, LLC. The group reports beneficial ownership of 315,275 shares of GeoVax common stock, representing 4.3% of the class as of June 30, 2026. All reported GeoVax shares are held with shared voting and dispositive power; none are held with sole voting or dispositive authority. Subsidiaries Jane Street Capital, LLC and Jane Street Global Trading, LLC report shared voting and dispositive power over 161,270 and 154,005 shares, respectively. The filing indicates ownership of 5 percent or less of GeoVax’s outstanding common stock.
Key Figures
Key Terms
beneficially owned financial
parent holding company financial
percent of class financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What percentage of GeoVax Labs, Inc. (GOVX) does Jane Street report owning?
Does Jane Street hold more than 5% of GeoVax Labs, Inc. (GOVX)?
What is the CUSIP and class of securities referenced for GeoVax (GOVX)?
AI-generated analysis. How Rhea-AI works. Not financial advice.